Dentons Biochemical sauor on alleged Dutch infringement

on August 9,, Dentons Biochemical Technology Group issued a notice on "suspected patent infringement in the Netherlands", and on August 6, 2013, the Group received a writ served by the Court Of Justice in The Hague, the Netherlands, on the alleged infringement of patent number EP1664318, entitled "The Method for the Production of L-amino acid microorganisms and the production of L-amino acids (L-amino-co-production-organism-stocking-for-the-company) "pHV
The proceedings are scheduled for the first day of hearings on 30 October 2013The plaintiff sought an interim order for the hearing to be held on 26 September 2013pHV
The Group is seeking legal advice on the above legal proceedings and is subject to further legal advice and a detailed assessment of its business and financial implications, and as at 31 December 2012, the Group sold l-lysine products to the Netherlands approximately US$11,602,000, or approximately 1 per cent of the Group's turnover for the year, and the Board believed that the legal process would not have any significant impact on the Group's overall financial or financial situationpHVAugust 9, Dentons Biochemical Technology Group issued a notice on "suspected patent infringement in the Netherlands", said that on August 6, 2013, the Group received a warrant served by the Court of Justice in The Hague, the Netherlands, the company's suspected infringement of patent number EP1664318 ,titled "The Method of Producing L-Amino Acid Microbes and The Production of L-amino-amino-co-production-company-company."pHV
The proceedings are scheduled for the first day of hearings on 30 October 2013The plaintiff sought an interim order for the hearing to be held on 26 September 2013pHV
　　The Group is seeking legal advice on the above legal proceedings and is subject to further legal advice and a detailed assessment of its business and financial implications, and as at 31 December 2012, the Group sold l-lysine products to the Netherlands approximately US$11,602,000, or approximately 1 per cent of the Group's turnover for the year, and the Board believed that the legal process would not have any significant impact on the Group's overall financial or financial situation pHV